A 60-year-old Danish woman who received the AstraZeneca COVID-19 vaccine had “extremely unusual symptoms” before dying from a blood clot, according to a report.
The woman had a low platelet count and blood clots in small and large vessels, Reuters reported, citing the Danish Medicines Agency.
The agency cited several similar cases reported in Norway and in the European Medicines Agency database on the side effects of medicines, according to the press.
“It was an unusual course of illness around the death that caused the Danish Medicines Agency to react,” it said in a statement on Sunday evening.
On Saturday, Norway said three people – all under the age of 50 – who had received jab were treated at a hospital for bleeding, blood clots and a low blood platelet count, which health officials said. they labeled “unusual symptoms.”
Denmark, Norway and Iceland said last week they would stop the AstraZeneca strike.
European vaccination programs have been shaken by recent reports that recipients of AstraZeneca inoculation have suffered blood clots.
The European Medicines Agency said there was no indication that the cases were related to vaccination, an opinion that was repeated by the World Health Organization on Friday.
AstraZeneca has tried to stifle safety issues after blood clots in some people, causing about a dozen nations to stop using some or all of their doses.
The British doctor’s review of safety data from more than 17 million people shot in the UK and the European Union found no evidence of an increased risk of pulmonary embolism or deep vein thrombosis, a condition associated with clots. in a statement on Sunday. .
There were also no signs of an increased risk of thrombocytopenia, a low platelet count, according to AstraZeneca.